En Es
Categories

Industry News

Radcal to Supply Quality Assurance X-Ray Testing Equipment to West Physics

By Medimaging International staff writers
11 Nov 2022

Image: West Physics will purchase 43 of the new Touch Professional series, Accu-Gold+ Touch Pro (Photo courtesy of Radcal)

Radcal Corporation (Monrovia, CA, USA), a leading manufacturer of diagnostic X-ray quality assurance (QA) meters, has reached an agreement with West Physics (Atlanta, GA, USA), one of the largest and most successful Medical Physics groups in the U.S., to supply QA X-ray testing equipment.


For over 40 years Radcal has been a steadfast partner in making accurate reliable radiation measurements for quality assurance, manufacturing, service, and compliance applications. The company’s modular product line is designed to be tailored to individual needs with the broadest array of sensors, systems, displays, and software. As part of the agreement, West Physics will purchase 43 of Radcal’s new Touch Professional series, Accu-Gold+ Touch Pro, which includes a new software-based measuring system capable of performing multiple operations with just one exposure. The agreement also includes light and multi-sensors, CTDI and scatter ion chambers, test stands, cables and carrying cases. The first X-ray test kits have already been delivered, with additional kits to be delivered in Q4 2022 and early 2023. The additional kits will support West Physics continued expansion and ensure it has up-to-date physics gear as older units are retired.


“Our independent business nature makes our products an attractive option for physicists around the world and we are committed to providing the most state-of-the-art, high-quality diagnostic X-ray testing equipment to ensure accurate and fast X-ray QA test results,” said Gustavo Tuntisi, territory director of Radcal Corporation. “The Accu-Gold+ Touch Pro is the most comprehensive system in Radcal’s product line, providing a tailored solution to reliably deliver powerful and fast X-ray quality assurance testing analytics.”


“Radcal’s Accu-Gold+ Touch Pro will be an important addition to West Physics’ scientific equipment inventory as we continue to expand,” added Dr. Geoffrey West, president and chief medical physicist of West Physics. “These new X-ray testing kits provide accuracy, reliability, and superior operating economics, and the agreement reflects our prudent approach to deploying our capital while ensuring extremely high levels of technical capability and customer service.”


Related Links:
Radcal Corporation 
West Physics 



E-mail Print
FaceBook Twitter Google+ Linked in

Radcal

Radcal is a premier provider of diagnostic X-ray measurements systems for quality assurance, manufacturing, service, and compliance applications. The company’s modular product line, comprising the broadest array of sensors, systems, displays and software, is designed to meet the client’s individual needs.
Silver member
More info

Additional news

25 Jan 2023
Global Diagnostic Imaging Services Market Driven by Rising Prevalence of Chronic Diseases
The global diagnostic imaging services market was valued at USD 40.80 billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period 2022-2030 to reach USD 67.94 billion in 2030, driven by the rising prevalence of chronic diseases, increasing elderly population, and rapid technological advancements in the healthcare diagnostic industry.
Read More
25 Jan 2023
Global Endoscopy Equipment Market Driven by Growing Hospital Investment in Advanced Instruments
The global endoscopy equipment market is projected to register a CAGR of 7% from USD 28.9 billion in 2022 to USD 40.6 billion by 2027, driven by increasing demand for endoscopy to diagnose and treat target diseases, rising investments, funds, and grants by governments and other organizations across the world, and growing focus by hospitals on investing in technologically-advanced endoscopy instruments and expanding endoscopy units.
Read More
25 Jan 2023
Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032
The global point-of-care (POC) glucose testing market is projected to register a CAGR of 4.3% during the forecast period from 2022 to 2032 to reach USD 5.8 billion by 2032, driven by a rise in the geriatric population, speed & precision of POC screening, increased adoption of electronic medical information, and the higher risk of COVID-19-related mortality associated with diabetes.
Read More
24 Jan 2023
Carolina Liquid Chemistries and Diazyme Enter Into Partnership
Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) and Diazyme Laboratories, Inc. (San Diego, CA, USA) have entered into a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer, allowing it to run both special and routine chemistries.
Read More
23 Jan 2023
Mindray Defibrillators Amongst the World’s First to Receive MDR Clearance
Mindray has received the CE marking for its defibrillation product family under the European Union's newest Medical Device Regulation (MDR). With the new rule tightening the controls for defibrillation devices, Mindray has become among the first manufacturers in the world to earn MDR accreditation for product quality and effectiveness.
Read More
23 Jan 2023
Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland
Siemens Healthineers has launched a Center of Excellence for Immunoassay Instrument Research and Development (R&D) in Swords, Ireland. The new center will focus on unlocking breakthrough innovations in laboratory instruments used to detect infectious diseases, cancer and blood disorders.
Read More
20 Jan 2023
Global Intensive Care Unit (ICU) Equipment Market Driven By Increasing Neurological Diseases
The global intensive care unit (ICU) equipment market was valued at USD 6.6 billion in 2021 and is estimated to register a CAGR of 3.9% from 2022 to 2031 to reach USD 9.6 billion by 2031, driven primarily by a rise in the prevalence of neurological diseases.
Read More
20 Jan 2023
Bayer Acquires Imaging AI Platform Provider in the UK
Bayer (Leverkusen, Germany) has acquired Blackford Analysis Ltd. (Edinburgh, UK), a global strategic imaging AI platform and solutions provider. The acquisition is part of Bayer's strategy to drive innovation in radiology, including the development and adoption of AI within the clinical workflow, with the goal to ultimately improve patient care and advance the company’s position in digital medical imaging.
Read More
16 Jan 2023
Medlab Middle East Sees 100% Increase in Exhibitor Numbers
Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, has sold out its exhibitor space ahead of the show, which returns to the Dubai World Trade Centre from February 6 to 9, 2023.
Read More
Copyright © 2000-2023 TradeMed.com. All rights reserved. | Terms And Conditions